La Jolla, CA-based Ambrx has raised $10 million in new venture funds, adding to the $70 million it has already raised from the likes of 5AM Ventures and Aravis and Versant. Ambrx has been developing a novel protein modification platform. Report [1]
Links:
[1] http://www.pehub.com/35989/ambrx-raises-10-million/